Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Health Catalyst (HCAT) EBIT (2018 - 2025)

Historic EBIT for Health Catalyst (HCAT) over the last 8 years, with Q3 2025 value amounting to -$17.5 million.

  • Health Catalyst's EBIT fell 2792.43% to -$17.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$92.3 million, marking a year-over-year decrease of 844.16%. This contributed to the annual value of -$69.8 million for FY2024, which is 4499.0% up from last year.
  • Per Health Catalyst's latest filing, its EBIT stood at -$17.5 million for Q3 2025, which was down 2792.43% from -$37.1 million recorded in Q2 2025.
  • In the past 5 years, Health Catalyst's EBIT registered a high of -$13.7 million during Q3 2024, and its lowest value of -$45.7 million during Q3 2022.
  • Over the past 5 years, Health Catalyst's median EBIT value was -$32.3 million (recorded in 2021), while the average stood at -$29.2 million.
  • Its EBIT has fluctuated over the past 5 years, first soared by 5433.88% in 2024, then tumbled by 13466.82% in 2025.
  • Quarter analysis of 5 years shows Health Catalyst's EBIT stood at -$44.8 million in 2021, then grew by 17.92% to -$36.7 million in 2022, then rose by 10.78% to -$32.8 million in 2023, then surged by 46.62% to -$17.5 million in 2024, then dropped by 0.05% to -$17.5 million in 2025.
  • Its EBIT stands at -$17.5 million for Q3 2025, versus -$37.1 million for Q2 2025 and -$20.2 million for Q1 2025.